The following table presents notable drug approvals of February 2025. Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) Meningococcal vaccine For active immunization to prevent invasive ...
The firm has “high confidence” that SER-252 will at least match the efficacy observed with other apomorphine delivery approaches, such as Supernus’ (SUPN) recently approved Onapgo ...
Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) Meningococcal vaccine For active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback